BRIEF-Sanofi Says Co, GSK To Support COVAX With 200 Mln Doses Of COVID-19 Vaccine
28 Oct 2020 / 14:06 H.
Oct 28 (Reuters) -
* SANOFI SAYS CO AND GSK TO SUPPORT COVAX WITH 200 MILLION DOSES OF ADJUVANTED, RECOMBINANT PROTEIN-BASED COVID-19 VACCINE
* SANOFI SAYS CO AND GSK HAVE SIGNED STATEMENT OF INTENT WITH GAVI, THE LEGAL ADMINISTRATOR OF THE COVAX FACILITY
* SANOFI SAYS CO, GSK INTEND TO MAKE AVAILABLE 200 MILLION DOSES OF ADJUVANTED RECOMBINANT PROTEIN-BASED COVID-19 VACCINE, IF APPROVED, TO COVAX FACILITY Source text for Eikon:
Did you like this article?
